The company reported a second-quarter earnings beat and raised full-year sales guidance, boosted by a strong performance at ...

More than half of severe COVID-19 survivors show fibrotic-like lung abnormalities even 3 years after infection, especially ...

U.S. bank Wells Fargo has suspended all travel to China after one of its employees was barred from leaving the country, a ...

The decline in the company's share price came as its shares traded ex-date following the announcement of a ₹32 per share ...

AstraZeneca (LSE:AZN) recently announced that its investigational antibody, anselamimab, did not achieve statistical ...

AstraZeneca’s anselamimab has failed to show any benefit in patients with light chain amyloidosis in two Phase III trials. A ...

AZN's anselamimab fails to meet key goals in late-stage AL amyloidosis trials despite signs of subgroup benefit.

Summit Therapeutics' HARMONi trial data for ivonescimab showed a clinical benefit but narrowly missed statistical ...

U.S. bank Wells Fargo has suspended all travel to China after one of its employees was barred from leaving the country, ...

Groundbreaking findings from Malaysia’s Heart2Miss heart failure screening programme were presented at the European Society ...

BEIJING: US bank Wells Fargo told AFP Friday it was working to help one of its employees return to the United States, after ...

In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a ...